tiprankstipranks
Trending News
More News >
Jyothy Labs Limited (IN:JYOTHYLAB)
:JYOTHYLAB
India Market
Advertisement

Jyothy Labs Limited (JYOTHYLAB) AI Stock Analysis

Compare
2 Followers

Top Page

IN:JYOTHYLAB

Jyothy Labs Limited

(JYOTHYLAB)

Rating:68Neutral
Price Target:
₹368.00
▲(8.68% Upside)
Jyothy Labs Limited's strong financial performance is the most significant factor, driven by consistent revenue and profit growth and effective cost management. However, technical indicators suggest a bearish trend, and the stock's valuation appears relatively high, which tempers the overall score.

Jyothy Labs Limited (JYOTHYLAB) vs. iShares MSCI India ETF (INDA)

Jyothy Labs Limited Business Overview & Revenue Model

Company DescriptionJyothy Labs Limited is an Indian multinational consumer goods company that operates in the fast-moving consumer goods (FMCG) sector. It was founded in 1983 and is headquartered in Mumbai, India. The company is engaged in the manufacturing and marketing of a wide range of products across categories like fabric care, dishwashing, household insecticides, personal care, and others. Some of its well-known brands include Ujala, Maxo, Exo, and Henko.
How the Company Makes MoneyJyothy Labs Limited generates revenue primarily through the sale of its diverse range of consumer goods in the FMCG sector. The company earns money by manufacturing and selling products across various categories such as fabric care, dishwashing, household insecticides, and personal care. Key revenue streams include sales from popular brands like Ujala for fabric whitening agents, Maxo for mosquito repellents, Exo for dishwashing solutions, and Henko for premium detergents. The company has a strong distribution network across India, which aids in reaching a vast customer base. Additionally, Jyothy Labs engages in marketing and promotional activities to enhance brand visibility and drive sales. While the company has some international presence, its primary market remains India. Strategic partnerships and collaborations with distributors and retailers also play a significant role in its revenue generation.

Jyothy Labs Limited Financial Statement Overview

Summary
Jyothy Labs Limited exhibits strong financial performance with consistent revenue and profit growth, effective cost management, and solid cash flow generation. The balance sheet is robust with low leverage, although a high equity ratio could limit financial flexibility. The company should focus on maintaining cash flow efficiency to sustain growth momentum.
Income Statement
82
Very Positive
Jyothy Labs Limited shows strong revenue growth with a consistent increase from INR 17,097 million in 2020 to INR 28,469 million in 2025. The gross profit margin has improved significantly, indicating efficient cost management and pricing strategies. Net profit margin has also remained stable, contributing to overall profitability. The EBIT and EBITDA margins reflect robust operational efficiency. However, attention is needed on the slight volatility in EBIT margins over the years.
Balance Sheet
78
Positive
The company maintains a solid balance sheet with a favorable debt-to-equity ratio, decreasing from 0.27 in 2020 to 0.03 in 2025, showcasing effective debt management and strong equity base. The return on equity is commendable, enhancing investor confidence. However, the equity ratio suggests a high reliance on equity financing, which could limit leverage benefits.
Cash Flow
76
Positive
Jyothy Labs has demonstrated strong cash flow generation with positive free cash flow growth. The operating cash flow to net income ratio indicates efficient conversion of income into cash, although there was a decline in operating cash flow in recent years. The company's free cash flow to net income ratio is solid, reflecting effective capital expenditure management. However, the decline in operating cash flow from 2024 to 2025 suggests potential challenges in cash generation operations.
BreakdownTTMDec 2025Dec 2023Dec 2023Dec 2021Dec 2021
Income Statement
Total Revenue28.47B28.47B24.86B27.55B19.08B21.95B
Gross Profit13.28B14.27B10.51B10.01B8.89B9.03B
EBITDA5.33B4.74B3.62B5.34B3.09B2.67B
Net Income3.70B3.70B2.40B3.69B1.99B1.62B
Balance Sheet
Total Assets26.91B26.91B20.62B24.01B19.56B20.23B
Cash, Cash Equivalents and Short-Term Investments5.99B5.99B2.86B6.16B1.87B2.04B
Total Debt612.80M612.80M465.30M505.60M1.67B1.71B
Total Liabilities6.41B6.41B5.11B5.91B5.65B6.20B
Stockholders Equity20.50B20.50B15.49B18.08B14.29B14.44B
Cash Flow
Free Cash Flow0.002.53B2.93B4.21B3.76B1.77B
Operating Cash Flow0.003.11B3.29B4.58B4.02B2.03B
Investing Cash Flow0.00-1.61B-482.90M-3.44B-1.29B-317.13M
Financing Cash Flow0.00-1.57B-2.51B-1.35B-2.16B-1.67B

Jyothy Labs Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price338.60
Price Trends
50DMA
335.72
Positive
100DMA
343.31
Negative
200DMA
359.32
Negative
Market Momentum
MACD
1.49
Negative
RSI
53.99
Neutral
STOCH
36.02
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:JYOTHYLAB, the sentiment is Neutral. The current price of 338.6 is above the 20-day moving average (MA) of 332.43, above the 50-day MA of 335.72, and below the 200-day MA of 359.32, indicating a neutral trend. The MACD of 1.49 indicates Negative momentum. The RSI at 53.99 is Neutral, neither overbought nor oversold. The STOCH value of 36.02 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:JYOTHYLAB.

Jyothy Labs Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
₹128.32B39.23
0.30%10.63%7.53%
74
Outperform
₹116.41B37.35
0.57%22.22%19.04%
69
Neutral
₹80.17B26.31
0.97%18.32%-0.43%
68
Neutral
₹124.71B34.12
1.03%1.59%-2.52%
67
Neutral
₹84.81B60.54
0.36%12.92%-4.82%
63
Neutral
$20.44B14.73-2.94%3.07%2.04%-6.12%
54
Neutral
₹95.33B129.14
4.91%-55.88%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:JYOTHYLAB
Jyothy Labs Limited
338.60
-207.25
-37.97%
IN:BECTORFOOD
Mrs. Bector's Food Specialities Ltd.
1,350.10
-273.68
-16.85%
IN:CCL
CCL Products (India) Limited
905.35
189.58
26.49%
IN:GALAXYSURF
Galaxy Surfactants Ltd.
2,261.30
-589.92
-20.69%
IN:HONASA
Honasa Consumer Limited
298.95
-206.50
-40.85%
IN:ZYDUSWELL
Zydus Wellness Limited
2,216.05
-15.35
-0.69%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 19, 2025